Daniel Arias
Stock Analyst at Stifel
(5.00)
# 5
Out of 5,053 analysts
160
Total ratings
59.34%
Success rate
149.14%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,453.30 | +10.09% | 8 | Nov 10, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $67 → $80 | $66.90 | +19.58% | 7 | Nov 4, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $70 | $97.79 | -28.42% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $40.75 | -1.84% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $11.66 | +2.96% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $93.74 | +17.35% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $58.99 | +1.71% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $579.37 | +7.01% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $213.32 | +21.88% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $1.50 | +500.00% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $17.35 | +3.75% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.05 | -0.83% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $71.41 | -8.98% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $383.25 | -6.07% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $147.60 | +2.30% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $43.83 | +5.75% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.06 | +226.80% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $147.25 | +40.58% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $123.68 | +61.71% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.80 | +177.78% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.26 | +207.22% | 2 | May 31, 2022 |
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,453.30
Upside: +10.09%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $67 → $80
Current: $66.90
Upside: +19.58%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $97.79
Upside: -28.42%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $40.75
Upside: -1.84%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $11.66
Upside: +2.96%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $93.74
Upside: +17.35%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $58.99
Upside: +1.71%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $579.37
Upside: +7.01%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $213.32
Upside: +21.88%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.50
Upside: +500.00%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $17.35
Upside: +3.75%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.05
Upside: -0.83%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $71.41
Upside: -8.98%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $383.25
Upside: -6.07%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $147.60
Upside: +2.30%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $43.83
Upside: +5.75%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.06
Upside: +226.80%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $147.25
Upside: +40.58%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $123.68
Upside: +61.71%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.80
Upside: +177.78%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.26
Upside: +207.22%